Drug Shortage Report for BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP

Last updated on 2023-05-27 History
Report ID 189687
Drug Identification Number 02512424
Brand name BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
Common or Proper name Bupivacaine Hydrochloride In Dextrose Injection USP
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) BUPIVACAINE HYDROCHLORIDE
Strength(s) 7.5MG
Dosage form(s) SOLUTION
Route of administration INTRASPINAL
Packaging size 10 x 2 mL vial / fiole
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-04-14
Estimated end date 2023-05-26
Actual end date 2023-05-26
Shortage status Resolved
Updated date 2023-05-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-04-14 English Compare
v2 2023-04-14 French Compare
v3 2023-04-15 English Compare
v4 2023-04-21 English Compare
v5 2023-04-21 French Compare
v6 2023-05-25 English Compare
v7 2023-05-25 French Compare
v8 2023-05-27 English Compare

Showing 1 to 8 of 8